Close

Oppenheimer Reiterates Outperform on Iovanace Biotherapeutics (IOVA) After Meeting with Management

August 18, 2017 8:31 AM EDT Send to a Friend
Oppenheimer reiterated an Outperform rating and $13.00 price target on Iovanace Biotherapeutics (NASDAQ: IOVA) after meeting with management. Discussions ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login